NEW YORK (GenomeWeb News) – A Harvard University cell biologist and cancer researcher told lawmakers on Monday that tightening budgets at the National Institutes of Health, if continued, could have “devastating” effects on new biomedical research fields, including genomics.
 
According to Joan Brugge, scaled back funding has already caused grants at the National Cancer Institute to decline between 24 to 29 percent, and has lowered success rates for initial investigators to 5 percent.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.